| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Internal Medicine | 18 / 179 | 89th | Q1 |
Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Amyloid
Amyloid is Scopus-indexed (Q1, CiteScore 12.5), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Taylor and Francis Ltd..
Checked against the index lists dated .
ISSN 1350-6129Verify ISSN ↗1744-2818Verify ISSN ↗
Publisher: Taylor and Francis Ltd.
Cost to publish: No APC data — check the publisher
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Quick answers
Is Amyloid indexed in Scopus?
Yes — actively indexed in Scopus, coverage 1994–present, best quartile Q1, CiteScore 12.5.
What quartile is Amyloid in Scopus?
Amyloid is Q1 in Internal Medicine (rank 18 of 179), by CiteScore 2025.
What is the impact factor of Amyloid?
Amyloid is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 12.5, which places it in quartile Q1 at the 89th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 2.194, quartile Q1, with an H-index of 82.
Who publishes Amyloid and what is its ISSN?
Amyloid is published by Taylor and Francis Ltd. Its print ISSN is 1350-6129 and its online ISSN is 1744-2818.
Is Amyloid covered under ONOS in India?
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Is Amyloid in Web of Science?
Yes — indexed in the Science Citation Index Expanded.
Is Amyloid open access?
No — it is not registered as an open-access journal in DOAJ or Scopus.
How well cited is Amyloid? — open metrics via OpenAlex
Amyloid has an h-index of 90 and a 2-year mean of 3.6 citations per paper (OpenAlex). Its Scopus CiteScore is 12.5, quartile Q1. On 2-year citations it ranks #39 of 172 Scopus journals in Internal Medicine.
Amyloid published 66 papers in 2025; its busiest recent year was 2019 with 150. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
Who publishes in Amyloid? — latest 100 articles, 2025–2026
In its latest 100 research articles (2025–2026), authors are most often from United States (28.2%), Japan (11.2%) and France (10.4%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Are there integrity warnings for Amyloid? — indicators, not proof of misconduct
Scopus status: Active. 2 retracted papers are recorded (1.1 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
- Scopus statusActive
- Retracted papers 2 · 1.1 per 1,000 papers
- Problematic Paper Screener flags None flagged
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Official sources & links
Community experience: reader comments on this journal
Related journals
8 journalsIndex data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.